生存素与生长因子-β复合物在乳腺癌血管生成中的作用
The role of survivin and transforming growth factor-β compounds in blood vessel formation of breast cancer
摘要
乳腺癌是女性常见的恶性肿瘤之一,据统计,乳腺癌发病率占妇女恶性肿瘤的第一位.晚期癌细胞远处转移危害较大,目前对其生长与扩散的研究已成为医学界研究的重点内容.研究已表明,血管生成在恶性肿瘤迅速增殖、转移中起着重要作用.生存素(survivin)和生长因子-β复合物(endoglin,CD105)在乳腺癌血管生成中具有重要作用,对其研究进展综述如下.
出处
《华北煤炭医学院学报》
2004年第6期741-742,共2页
Journal of North China Coal Medical College
参考文献14
-
1[1]Lastres P,Letamendia A,Zhang H,et al.Endoglin modulates cellular responses to TGF-β1[J].Journal of Cell Biology,1996,133(8):1109-1121.
-
2[2]Suzuki A,Ito T,Kawano H,et al.Survivin initiates ptrocapase 3/p21 complex formation as a result of interaction with CDK4 to resist Fas mediated cell death[J].Oncogene ,2000,19(10):1346-1353.
-
3[3]Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,Survivin,expressed in cancer and lymphoma[J].Nature Med,1997,3(8):917.
-
4[4]TAndreas P,David F,Keyvan M,et al.Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/surviving pathway[J].The Journal of Biological Chemistry,2000,275(13):9102.
-
5[5]Cheifetz S,Bellon T, Cales C.et al.Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells[J].Journal of Biology Chemistry,1992,267(10):19027-19030.
-
6[6]Li DY,Sorensen LK,Brooke BS,et al.Defective angiogenesis in mice lacking endoglin[J].Science,1999,284(5419):1534-1537.
-
7[7]Li C,Hampson IN,hampson L,et al.CD105 antagonizes the inhibitory signaling of transforming growth factor betal on human vascular endothelial cells[J].FASEB J,2000,14(1):55-64.
-
8[8]Fonsatti E,Jekunen AP,Kairemo KJ,et al.Endooglin is a suitable target for efficient of solid tumors:in vivo evidence in a canine mammary carcinoma model[J].Cliin Cancer Res,2000,6(5):2037-2043.
-
9[9]Bodey B,Bodey B Jr,Siegel SE,et al. Over-expression of endoglin(CD105):a marker of breast carcinoma-induced neo-vascularization[J].Anticancer Res,1998,18(5A):3621-3628.
-
10[10]Akagi K,Ikeda Y,SumiyoshiY,et al.Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development[J].Surgery,2002,131(1 Suppl):S109-113.
-
1范丽梅,刘国辉,于金海.胃癌组织中端粒酶检测及血清癌胚抗原及癌抗原125检测的临床意义[J].中国实验诊断学,2010,14(11):1837-1839. 被引量：1
-
22015年各期重点内容[J].中华内分泌外科杂志,2014,8(6):527-528. 被引量：1
-
3王志平,陈一戎,刘国栋.前列腺癌及前列腺增生细胞转化生长因子－β受体分析[J].中华医学杂志,1994,74(11):693-694. 被引量：1
-
4张力.2010年第1版NCCN临床肿瘤治疗指南小细胞肺癌部分解读[J].国际呼吸杂志,2010(22):1355-1357. 被引量：8
-
5伍彩雯,杨采莲,王永荣,高新明.血管内皮生长因子-β在人绒毛膜癌中的作用研究[J].河北医药,2014,36(6):886-887. 被引量：1
-
6王东,肖华亮,李增鹏,陈俐.骨肉瘤碱性纤维生长因子、转化生长因子β_1及其受体表达与血管生成的关系[J].癌症,1999,18(2):142-145. 被引量：7
-
7赵源庆,赵书佑.颈部淋巴结转移癌的诊断和治疗研究进展[J].山东大学耳鼻喉眼学报,2006,20(5):456-461. 被引量：6
-
8张健,周士福.CD105与恶性肿瘤[J].淮海医药,2003,21(6):513-515. 被引量：2
-
9艾毅钦,王秦秦.Endoglin在肿瘤血管生成中的意义[J].云南医药,2007,28(4):408-410.
-
10王珏(综述),殷咏梅(审校).CD44与抗乳腺癌药物耐药性的关系[J].国际肿瘤学杂志,2009,36(7):521-524.
